Funding for this research was provided by:
Canadian Institutes of Health Research (MFE-142936)
National Institute of General Medical Sciences (5T32GM080178-12)
American Heart Association (16FTF30130005)
National Institutes of Health (5U54MD010722-04, GM130791-01, 1R01MH118233-01, UL1TR000427, 1U24CA242637-01, 5R01MH113362-03, 1R56MH120736-01)
Received: 25 February 2020
Accepted: 8 December 2020
First Online: 13 January 2021
Ethics approval and consent to participate
: BioVU Consent form is provided to patients in the outpatient clinic environments at VUMC. The consent states policies on data sharing and privacy and, upon consent, makes any blood leftover from clinical care eligible for BioVU banking. The VUMC Institutional Review Board oversees BioVU and approved this project. All data included in this study was de-identified and unlinked to any identifying information. This study was reviewed by the Vanderbilt University Medical Center IRB (IRB#172020) and designated as non-human subjects research. The research was conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable
: JWS is an unpaid member of the Bipolar/Depression Research Community Advisory Panel of 23andMe, is a member of the Leon Levy Foundation Neuroscience Advisory Board, and received an honorarium for an internal seminar at Biogen, Inc. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments. The remaining authors declare that they have no competing interests.